PHIBRO ANIMAL HEALTH CORP

For the period ended Mar 31, 2026. Filed May 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 6, 2026

PAHC$34.61+5.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

· · · · · ·
· · March 31, · · June 30,
As of · · 2026 · · 2025
· · (unaudited)
· (in thousands, except share and per share amounts)
ASSETS · · · · · ·
Cash and cash equivalents	$54,929	$68,039
Short-term investments	22,522	9,000
Accounts receivable, net	221,546	227,983
Inventories, net	539,699	444,425
Other current assets	55,372	61,159
Total current assets	894,068	810,606
Property, plant and equipment, net	359,271	354,690
Intangibles, net	31,685	36,469
Goodwill	59,889	59,645
Other assets	100,205	99,490
Total assets	$1,445,118	$1,360,900
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt	$22,831	$16,250
Accounts payable	129,643	138,201
Accrued expenses and other current liabilities	129,396	139,022
Total current liabilities	281,870	293,473
Revolving credit facility	115,000	87,000
Long-term debt	597,685	615,435
Other liabilities	88,736	79,310
Total liabilities	1,083,291	1,075,218
Commitments and contingencies (Note 9)
Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 20,968,682 and 20,367,574 shares issued and outstanding at March 31, 2026 and June 30, 2025, respectively; 30,000,000 Class B shares authorized, 19,596,034 and 20,166,034 shares issued and outstanding at March 31, 2026 and June 30, 2025, respectively	4	4
Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding	—	—
Paid-in capital	138,179	136,995
Retained earnings	336,115	272,701
Accumulated other comprehensive loss	(112,471)	(124,018)
Total stockholders’ equity	361,827	285,682
Total liabilities and stockholders’ equity	$1,445,118	$1,360,900

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.